Delivery Order SPE2DR25D6028-SPE2DR26FATDS
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $33,000 to AmerisourceBergen Drug Corp for the supply of Glucagon 1 mg emergency auto-injectors. The contract, awarded on December 30, 2025, with an ultimate completion date of January 28, 2026, was competitively awarded with firm fixed pricing and no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a $4,596.73 delivery order to AmerisourceBergen Drug Corp for the supply of Glucagon 1 mg emergency auto-injectors. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and carries an ultimate completion date of November 25, 2025. The delivery order was issued on October 28, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $56,339.90 for Glucagon 1 mg Emergency auto-injectors on July 17, 2025. This competitively awarded, firm fixed-price delivery order is expected to be completed by August 13, 2025, with performance at the awardee's Conshohocken facility. The contract is funded by the Department of Defense's Medical Supply Chain and represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,736.50 to AmerisourceBergen Drug Corp for Glucagon 1 MG Emergency Kits, with a completion deadline of December 31, 2025. This competitive, firm fixed-price delivery order was issued on December 30, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, was...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Glucagon 1 mg emergency auto-injectors. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $4,363.85 and is scheduled for completion by September 24, 2025. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,952.53 to AmerisourceBergen Drug Corp for Glucagon 1 mg emergency kits, with an ultimate completion date of December 30, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $8,844.19 to AmerisourceBergen Drug Corp for the supply of Glucagon 1 mg vials. This competitively awarded, firm fixed price contract has an ultimate completion date of September 4, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will fulfill this delivery order from its...
- The Defense Logistics Agency awarded a delivery order valued at $2,359.56 to AmerisourceBergen Drug Corp for Glucagon 1 mg Emergency Kits, with an ultimate completion date of December 4, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The performance location is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,504.43 to AmerisourceBergen Drug Corp for the supply of Glucagon 1 mg Emergency Kits. The contract is a firm fixed-price delivery order with an ultimate completion date of June 20, 2025, and was awarded on June 18, 2025. The award was made without a set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,723.89 to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Glucagon 1 mg Emergency Kits. This is a firm fixed-price delivery order with an ultimate completion date of August 25, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is a child contract...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FATDSDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,785.79 to AmerisourceBergen Drug Corp for the supply of Glucagon 1 mg emergency auto-injectors, with a completion date of January 27, 2026. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen Drug Corp's Corporate Office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling supply of a vast range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This specific delivery order for emergency glucagon auto-injectors supports the Defense Health Agency and other government healthcare systems through the flexible contract vehicle, addressing critical medical commodities needed for emergency response and diabetes management within the military healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.8k | 12/28/25 |